OPGN logo

OpGen, Inc


OPGN: OpGen Inc is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It is developing molecular information products and services for healthcare settings, helping to guide clinicians with rapid and actionable information about life-threatening infections, improve patient outcomes, and decrease the spread of infections caused by MDROs. Its proprietary DNA tests and informatics address the rising threat of antibiotic resistance by helping physicians and other healthcare providers optimize care decisions for patients with acute infections. The company's product candidates and services combine its Acuitas molecular diagnostics and Acuitas Lighthouse informatics platform for use with its curated MDRO knowledge base.


Show OPGN Financials

Consumer Interest
SEC Filings

Recent trades of OPGN by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by OPGN's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

  • $10,000 Jul 10, 2009 Issue: Defense
  • $20,000 Apr 17, 2009 Issue: Defense
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of OPGN in WallStreetBets Daily Discussion


Recent insights relating to OPGN

CNBC Recommendations

Recent picks made for OPGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in OPGN

Corporate Flights

Flights by private jets registered to OPGN